Tag: Choice Therapeutics
Alliqua buys Choice Therapeutics
May 6, 2014HME News Staff
LANGHORNE, Pa. - Alliqua, a provider of advanced wound care products, has acquired Choice Therapeutics for $4 million in stock and cash. The agreement, effective May 5, provides for an additional contingency payment of up to $5 million in stock or cash if stated revenue thresholds are reached over the next three years ending April 30, 2017. Alliqua has acquired Choice's wound care portfolio, its technology platform, and its sales and marketing team. The portfolio includes a TheraBond Antimicrobial...
Alliqua BioMedical, Choice Therapeutics, Mergers & Acquisitions (M&A), Wound Care
Sponsored Stories
SOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office
By John Koch, COO and co-founder, MediStreams